<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37948194</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-2099</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of general virology</Title><ISOAbbreviation>J Gen Virol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and the DNA damage response.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">001918</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1099/jgv.0.001918</ELocationID><Abstract><AbstractText>The recent coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by respiratory distress, multiorgan dysfunction and, in some cases, death. The virus is also responsible for post-COVID-19 condition (commonly referred to as 'long COVID'). SARS-CoV-2 is a single-stranded, positive-sense RNA virus with a genome of approximately 30&#x2009;kb, which encodes 26 proteins. It has been reported to affect multiple pathways in infected cells, resulting, in many cases, in the induction of a 'cytokine storm' and cellular senescence. Perhaps because it is an RNA virus, replicating largely in the cytoplasm, the effect of SARS-Cov-2 on genome stability and DNA damage responses (DDRs) has received relatively little attention. However, it is now becoming clear that the virus causes damage to cellular DNA, as shown by the presence of micronuclei, DNA repair foci and increased comet tails in infected cells. This review considers recent evidence indicating how SARS-CoV-2 causes genome instability, deregulates the cell cycle and targets specific components of DDR pathways. The significance of the virus's ability to cause cellular senescence is also considered, as are the implications of genome instability for patients suffering from long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grand</LastName><ForeName>Roger J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Institute for Cancer and Genomic Science, The Medical School, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Gen Virol</MedlineTA><NlmUniqueID>0077340</NlmUniqueID><ISSNLinking>0022-1317</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042822" MajorTopicYN="N">Genomic Instability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">DNA repair</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">senescence</Keyword></KeywordList><CoiStatement>The author declares that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37948194</ArticleId><ArticleId IdType="pmc">PMC10768691</ArticleId><ArticleId IdType="doi">10.1099/jgv.0.001918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almas T, Malik J, Alsubai AK, Jawad Zaidi SM, Iqbal R, et al. Post-acute COVID-19 syndrome and its prolonged effects: an updated systematic review. Ann Med Surg. 2022;80:103995. doi: 10.1016/j.amsu.2022.103995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103995</ArticleId><ArticleId IdType="pmc">PMC9197790</ArticleId><ArticleId IdType="pubmed">35721785</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31:210185. doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L, Khunti K. Long covid: risk factors, outcomes, and future directions for research. BMJ Med. 2022;1:e000257. doi: 10.1136/bmjmed-2022-000257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000257</ArticleId><ArticleId IdType="pmc">PMC9978746</ArticleId><ArticleId IdType="pubmed">36936586</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, et al. Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-M, Chung Y-S, Jo HJ, Lee N-J, Kim MS, et al. Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect. 2020;11:3&#x2013;7. doi: 10.24171/j.phrp.2020.11.1.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2020.11.1.02</ArticleId><ArticleId IdType="pmc">PMC7045880</ArticleId><ArticleId IdType="pubmed">32149036</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155&#x2013;170. doi: 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartenian E, Nandakumar D, Lari A, Ly M, Tucker JM, et al. The molecular virology of coronaviruses. J Biol Chem. 2020;295:12910&#x2013;12934. doi: 10.1074/jbc.REV120.013930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV120.013930</ArticleId><ArticleId IdType="pmc">PMC7489918</ArticleId><ArticleId IdType="pubmed">32661197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahirul Islam M, Nawal Islam N, Siddik Alom M, Kabir M, Halim MA. A review on structural, non-structural, and accessory proteins of SARS-CoV-2: highlighting drug target sites. Immunobiology. 2023;228:152302. doi: 10.1016/j.imbio.2022.152302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2022.152302</ArticleId><ArticleId IdType="pmc">PMC9663145</ArticleId><ArticleId IdType="pubmed">36434912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, et al. Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2. Infect Genet Evol. 2021;89:104490. doi: 10.1016/j.meegid.2020.104490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2020.104490</ArticleId><ArticleId IdType="pmc">PMC7395230</ArticleId><ArticleId IdType="pubmed">32745811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19:685&#x2013;700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Zhao S, Yu B, Chen Y-M, Wang W, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;580:E7. doi: 10.1038/s41586-020-2202-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2202-3</ArticleId><ArticleId IdType="pmc">PMC7608129</ArticleId><ArticleId IdType="pubmed">32296181</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan K, Wei P, Feng Q, Chen S, Huang C, et al. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J Biol Chem. 2004;279:1637&#x2013;1642. doi: 10.1074/jbc.M310875200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M310875200</ArticleId><ArticleId IdType="pmc">PMC7980035</ArticleId><ArticleId IdType="pubmed">14561748</ArticleId></ArticleIdList></Reference><Reference><Citation>Harcourt BH, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson KM, et al. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol. 2004;78:13600&#x2013;13612. doi: 10.1128/JVI.78.24.13600-13612.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.24.13600-13612.2004</ArticleId><ArticleId IdType="pmc">PMC533933</ArticleId><ArticleId IdType="pubmed">15564471</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Du X, Xu Y, Deng Y, Liu M, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289&#x2013;293. doi: 10.1038/s41586-020-2223-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2223-y</ArticleId><ArticleId IdType="pubmed">32272481</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemm T, Ebert G, Calleja DJ, Allison CC, Richardson LW, et al. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. EMBO J. 2020;39:e106275. doi: 10.15252/embj.2020106275.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106275</ArticleId><ArticleId IdType="pmc">PMC7461020</ArticleId><ArticleId IdType="pubmed">32845033</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66:801&#x2013;817. doi: 10.1016/j.molcel.2017.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.05.015</ArticleId><ArticleId IdType="pubmed">28622525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179&#x2013;204. doi: 10.1016/j.molcel.2010.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.09.019</ArticleId><ArticleId IdType="pmc">PMC2988877</ArticleId><ArticleId IdType="pubmed">20965415</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AJ, Chen DJ. DNA double strand break repair via non-homologous end-joining. Transl Cancer Res. 2013;2:130&#x2013;143. doi: 10.3978/j.issn.2218-676X.2013.04.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2218-676X.2013.04.02</ArticleId><ArticleId IdType="pmc">PMC3758668</ArticleId><ArticleId IdType="pubmed">24000320</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18:495&#x2013;506. doi: 10.1038/nrm.2017.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.48</ArticleId><ArticleId IdType="pmc">PMC7062608</ArticleId><ArticleId IdType="pubmed">28512351</ArticleId></ArticleIdList></Reference><Reference><Citation>Spies J, Polasek-Sedlackova H, Lukas J, Somyajit K. Homologous recombination as a fundamental genome surveillance mechanism during DNA replication. Genes. 2021;12:12. doi: 10.3390/genes12121960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12121960</ArticleId><ArticleId IdType="pmc">PMC8701046</ArticleId><ArticleId IdType="pubmed">34946909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright WD, Shah SS, Heyer WD. Homologous recombination and the repair of DNA double-strand breaks. J Biol Chem. 2018;293:10524&#x2013;10535. doi: 10.1074/jbc.TM118.000372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.000372</ArticleId><ArticleId IdType="pmc">PMC6036207</ArticleId><ArticleId IdType="pubmed">29599286</ArticleId></ArticleIdList></Reference><Reference><Citation>Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic Acids Res. 2012;40:5795&#x2013;5818. doi: 10.1093/nar/gks270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks270</ArticleId><ArticleId IdType="pmc">PMC3401455</ArticleId><ArticleId IdType="pubmed">22467216</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Pearlman AH, Hsieh P. DNA mismatch repair and the DNA damage response. DNA Repair. 2016;38:94&#x2013;101. doi: 10.1016/j.dnarep.2015.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2015.11.019</ArticleId><ArticleId IdType="pmc">PMC4740233</ArticleId><ArticleId IdType="pubmed">26704428</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G-M. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18:85&#x2013;98. doi: 10.1038/cr.2007.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2007.115</ArticleId><ArticleId IdType="pubmed">18157157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ijsselsteijn R, Jansen JG, de Wind N. DNA mismatch repair-dependent DNA damage responses and cancer. DNA Repair. 2020;93:102923. doi: 10.1016/j.dnarep.2020.102923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2020.102923</ArticleId><ArticleId IdType="pubmed">33087264</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishel R. Mismatch repair. J Biol Chem. 2015;290:26395&#x2013;26403. doi: 10.1074/jbc.R115.660142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R115.660142</ArticleId><ArticleId IdType="pmc">PMC4646297</ArticleId><ArticleId IdType="pubmed">26354434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde ML, Hazra TK, Mitra S. Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res. 2008;18:27&#x2013;47. doi: 10.1038/cr.2008.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2008.8</ArticleId><ArticleId IdType="pmc">PMC2692221</ArticleId><ArticleId IdType="pubmed">18166975</ArticleId></ArticleIdList></Reference><Reference><Citation>Dianov GL, H&#xfc;bscher U. Mammalian base excision repair: the forgotten archangel. Nucleic Acids Res. 2013;41:3483&#x2013;3490. doi: 10.1093/nar/gkt076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt076</ArticleId><ArticleId IdType="pmc">PMC3616742</ArticleId><ArticleId IdType="pubmed">23408852</ArticleId></ArticleIdList></Reference><Reference><Citation>Spivak G. Nucleotide excision repair in humans. DNA Repair. 2015;36:13&#x2013;18. doi: 10.1016/j.dnarep.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2015.09.003</ArticleId><ArticleId IdType="pmc">PMC4688078</ArticleId><ArticleId IdType="pubmed">26388429</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon JT, Sancar A. Nucleotide excision repair. Prog Nucleic Acid Res Mol Biol. 2005;79:183&#x2013;235. doi: 10.1016/S0079-6603(04)79004-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0079-6603(04)79004-2</ArticleId><ArticleId IdType="pubmed">16096029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccaldi R, Sarangi P, D&#x2019;Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17:337&#x2013;349. doi: 10.1038/nrm.2016.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.48</ArticleId><ArticleId IdType="pubmed">27145721</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23&#x2013;34. doi: 10.1038/nrc970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc970</ArticleId><ArticleId IdType="pubmed">12509764</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AMR, Rothblum-Oviatt C, Ellis NA, Hickson ID, Meyer S, et al. Chromosome instability syndromes. Nat Rev Dis Primers. 2019;5:64. doi: 10.1038/s41572-019-0113-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0113-0</ArticleId><ArticleId IdType="pmc">PMC10617425</ArticleId><ArticleId IdType="pubmed">31537806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaina B, Christmann M, Naumann S, Roos WP. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair. 2007;6:1079&#x2013;1099. doi: 10.1016/j.dnarep.2007.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2007.03.008</ArticleId><ArticleId IdType="pubmed">17485253</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez R, O&#x2019;Connor TR. DNA direct reversal repair and alkylating agent drug resistance. Cancer Drug Resist. 2021;4:414&#x2013;423. doi: 10.20517/cdr.2020.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.20517/cdr.2020.113</ArticleId><ArticleId IdType="pmc">PMC9019270</ArticleId><ArticleId IdType="pubmed">35582025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth R, Grand RJ. Modulation of DNA damage and repair pathways by human tumour viruses. Viruses. 2015;7:2542&#x2013;2591. doi: 10.3390/v7052542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7052542</ArticleId><ArticleId IdType="pmc">PMC4452920</ArticleId><ArticleId IdType="pubmed">26008701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan EL, Hollingworth R, Grand RJ. Activation of the DNA damage response by RNA viruses. Biomolecules. 2016;6:2. doi: 10.3390/biom6010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom6010002</ArticleId><ArticleId IdType="pmc">PMC4808796</ArticleId><ArticleId IdType="pubmed">26751489</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnell AS, Grand RJ. DNA viruses and the cellular DNA-damage response. J Gen Virol. 2012;93:2076&#x2013;2097. doi: 10.1099/vir.0.044412-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.044412-0</ArticleId><ArticleId IdType="pubmed">22855786</ArticleId></ArticleIdList></Reference><Reference><Citation>Pancholi NJ, Price AM, Weitzman MD. Take your PIKK: tumour viruses and DNA damage response pathways. Philos Trans R Soc Lond B Biol Sci. 2017;372:1732. doi: 10.1098/rstb.2016.0269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0269</ArticleId><ArticleId IdType="pmc">PMC5597736</ArticleId><ArticleId IdType="pubmed">28893936</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitzman MD, Fradet-Turcotte A. Virus DNA replication and the host DNA damage response. Annu Rev Virol. 2018;5:141&#x2013;164. doi: 10.1146/annurev-virology-092917-043534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092917-043534</ArticleId><ArticleId IdType="pmc">PMC6462412</ArticleId><ArticleId IdType="pubmed">29996066</ArticleId></ArticleIdList></Reference><Reference><Citation>Luftig MA. Viruses and the DNA damage response: activation and antagonism. Annu Rev Virol. 2014;1:605&#x2013;625. doi: 10.1146/annurev-virology-031413-085548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-031413-085548</ArticleId><ArticleId IdType="pubmed">26958736</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitzman MD, Lilley CE, Chaurushiya MS. Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol. 2010;64:61&#x2013;81. doi: 10.1146/annurev.micro.112408.134016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.112408.134016</ArticleId><ArticleId IdType="pubmed">20690823</ArticleId></ArticleIdList></Reference><Reference><Citation>Stracker TH, Carson CT, Weitzman MD. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 2002;418:348&#x2013;352. doi: 10.1038/nature00863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00863</ArticleId><ArticleId IdType="pubmed">12124628</ArticleId></ArticleIdList></Reference><Reference><Citation>Orazio NI, Naeger CM, Karlseder J, Weitzman MD. The adenovirus E1b55K/E4orf6 complex induces degradation of the bloom helicase during infection. J Virol. 2011;85:1887&#x2013;1892. doi: 10.1128/JVI.02134-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02134-10</ArticleId><ArticleId IdType="pmc">PMC3028918</ArticleId><ArticleId IdType="pubmed">21123383</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaurushiya MS, Lilley CE, Aslanian A, Meisenhelder J, Scott DC, et al. Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain. Mol Cell. 2012;46:79&#x2013;90. doi: 10.1016/j.molcel.2012.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.02.004</ArticleId><ArticleId IdType="pmc">PMC3648639</ArticleId><ArticleId IdType="pubmed">22405594</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson J, Lees-Miller SP, Everett RD. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol. 1999;73:650&#x2013;657. doi: 10.1128/JVI.73.1.650-657.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.1.650-657.1999</ArticleId><ArticleId IdType="pmc">PMC103871</ArticleId><ArticleId IdType="pubmed">9847370</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiaofei E, Kowalik TF. The DNA damage response induced by infection with human cytomegalovirus and other viruses. Viruses. 2014;6:2155&#x2013;2185. doi: 10.3390/v6052155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6052155</ArticleId><ArticleId IdType="pmc">PMC4036536</ArticleId><ArticleId IdType="pubmed">24859341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemeier SR, Barlow EA, Meng Q, Kenney SC. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J Virol. 2012;86:13360&#x2013;13370. doi: 10.1128/JVI.01850-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01850-12</ArticleId><ArticleId IdType="pmc">PMC3503132</ArticleId><ArticleId IdType="pubmed">23015717</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth R, Horniblow RD, Forrest C, Stewart GS, Grand RJ. Localization of double-strand break repair proteins to viral replication compartments following lytic reactivation of Kaposi&#x2019;s sarcoma-associated herpesvirus. J Virol. 2017;91:e00930-17. doi: 10.1128/JVI.00930-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00930-17</ArticleId><ArticleId IdType="pmc">PMC5660498</ArticleId><ArticleId IdType="pubmed">28855246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilley CE, Carson CT, Muotri AR, Gage FH, Weitzman MD. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc Natl Acad Sci U S A. 2005;102:5844&#x2013;5849. doi: 10.1073/pnas.0501916102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501916102</ArticleId><ArticleId IdType="pmc">PMC556126</ArticleId><ArticleId IdType="pubmed">15824307</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Zhu J, Xie Z, Liao G, Liu J, et al. Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe. 2011;10:390&#x2013;400. doi: 10.1016/j.chom.2011.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.08.013</ArticleId><ArticleId IdType="pmc">PMC3253558</ArticleId><ArticleId IdType="pubmed">22018239</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Dodson GE, Shaikh S, Rundell K, Tibbetts RS. Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J Biol Chem. 2005;280:40195&#x2013;40200. doi: 10.1074/jbc.C500400200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C500400200</ArticleId><ArticleId IdType="pubmed">16221684</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl J, You J, Benjamin TL. Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol. 2005;79:13007&#x2013;13017. doi: 10.1128/JVI.79.20.13007-13017.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.20.13007-13017.2005</ArticleId><ArticleId IdType="pmc">PMC1235815</ArticleId><ArticleId IdType="pubmed">16189003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth R, Skalka GL, Stewart GS, Hislop AD, Blackbourn DJ, et al. Activation of DNA damage response pathways during lytic replication of KSHV. Viruses. 2015;7:2908&#x2013;2927. doi: 10.3390/v7062752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7062752</ArticleId><ArticleId IdType="pmc">PMC4488719</ArticleId><ArticleId IdType="pubmed">26057167</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackford AN, Bruton RK, Dirlik O, Stewart GS, Taylor AMR, et al. A role for E1B-AP5 in ATR signaling pathways during adenovirus infection. J Virol. 2008;82:7640&#x2013;7652. doi: 10.1128/JVI.00170-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00170-08</ArticleId><ArticleId IdType="pmc">PMC2493339</ArticleId><ArticleId IdType="pubmed">18480432</ArticleId></ArticleIdList></Reference><Reference><Citation>Daikoku T, Kudoh A, Sugaya Y, Iwahori S, Shirata N, et al. Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments. J Biol Chem. 2006;281:11422&#x2013;11430. doi: 10.1074/jbc.M510314200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M510314200</ArticleId><ArticleId IdType="pubmed">16510450</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie KA, Mehta KP, Laimins LA, Moody CA. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol. 2012;86:9520&#x2013;9526. doi: 10.1128/JVI.00247-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00247-12</ArticleId><ArticleId IdType="pmc">PMC3416172</ArticleId><ArticleId IdType="pubmed">22740399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hau PM, Deng W, Jia L, Yang J, Tsurumi T, et al. Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells. J Virol. 2015;89:652&#x2013;668. doi: 10.1128/JVI.01437-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01437-14</ArticleId><ArticleId IdType="pmc">PMC4301132</ArticleId><ArticleId IdType="pubmed">25355892</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang SH, Wang X, Li J, Buck CB, You J. Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J Virol. 2014;88:3285&#x2013;3297. doi: 10.1128/JVI.03656-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03656-13</ArticleId><ArticleId IdType="pmc">PMC3957940</ArticleId><ArticleId IdType="pubmed">24390338</ArticleId></ArticleIdList></Reference><Reference><Citation>Denison MR. Seeking membranes: positive-strand RNA virus replication complexes. PLoS Biol. 2008;6:e270. doi: 10.1371/journal.pbio.0060270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060270</ArticleId><ArticleId IdType="pmc">PMC2573941</ArticleId><ArticleId IdType="pubmed">18959488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska JB, Lagodzinski A, Berezinska M. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment. J Physiol Pharmacol. 2021;72 doi: 10.26402/jpp.2021.4.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.26402/jpp.2021.4.01</ArticleId><ArticleId IdType="pubmed">34987123</ArticleId></ArticleIdList></Reference><Reference><Citation>Howley PM, Knipe DM, Whelan S, Freed EO, Cohen JL, editors. Wolters Kluwer Philadelphia; 2022. Fields Virology: Volume 3, RNA Viruses .</Citation></Reference><Reference><Citation>Clavarino G, Cl&#xe1;udio N, Couderc T, Dalet A, Judith D, et al. Induction of GADD34 is necessary for dsRNA-dependent interferon-&#x3b2; production and participates in the control of Chikungunya virus infection. PLoS Pathog. 2012;8:e1002708. doi: 10.1371/journal.ppat.1002708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002708</ArticleId><ArticleId IdType="pmc">PMC3355096</ArticleId><ArticleId IdType="pubmed">22615568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nargi-Aizenman JL, Simbulan-Rosenthal CM, Kelly TA, Smulson ME, Griffin DE. Rapid activation of poly(ADP-ribose) polymerase contributes to Sindbis virus and staurosporine-induced apoptotic cell death. Virology. 2002;293:164&#x2013;171. doi: 10.1006/viro.2001.1253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1253</ArticleId><ArticleId IdType="pubmed">11853409</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachiwana H, Shimura M, Nakai-Murakami C, Tokunaga K, Takizawa Y, et al. HIV-1 Vpr induces DNA double-strand breaks. Cancer Res. 2006;66:627&#x2013;631. doi: 10.1158/0008-5472.CAN-05-3144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-05-3144</ArticleId><ArticleId IdType="pubmed">16423988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakai-Murakami C, Shimura M, Kinomoto M, Takizawa Y, Tokunaga K, et al. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene. 2007;26:477&#x2013;486. doi: 10.1038/sj.onc.1209831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209831</ArticleId><ArticleId IdType="pubmed">16983346</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Parrish M, Chan TK, Yin L, Rai P, et al. Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration. Cell Mol Life Sci. 2015;72:2973&#x2013;2988. doi: 10.1007/s00018-015-1879-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-1879-1</ArticleId><ArticleId IdType="pmc">PMC4802977</ArticleId><ArticleId IdType="pubmed">25809161</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijaya Lakshmi AN, Ramana MV, Vijayashree B, Ahuja YR, Sharma G. Detection of influenza virus induced DNA damage by comet assay. Mutat Res. 1999;442:53&#x2013;58. doi: 10.1016/s1383-5718(99)00058-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1383-5718(99)00058-3</ArticleId><ArticleId IdType="pubmed">10366773</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;nico P, Ostrosky-Wegman P, Salazar AM. The potential role of COVID-19 in the induction of DNA damage. Mutat Res Rev Mutat Res. 2022;789:108411. doi: 10.1016/j.mrrev.2022.108411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrrev.2022.108411</ArticleId><ArticleId IdType="pmc">PMC8767986</ArticleId><ArticleId IdType="pubmed">35690420</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanikolaou C, Rapti V, Stellas D, Stefanou DT, Syrigos K, et al. Delineating the SARS-CoV-2 induced interplay between the host immune system and the DNA damage response network. Vaccines. 2022;10:10. doi: 10.3390/vaccines10101764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101764</ArticleId><ArticleId IdType="pmc">PMC9610764</ArticleId><ArticleId IdType="pubmed">36298629</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562&#x2013;569. doi: 10.1038/s41564-020-0688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;183:1735. doi: 10.1016/j.cell.2020.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.032</ArticleId><ArticleId IdType="pmc">PMC7833104</ArticleId><ArticleId IdType="pubmed">33306958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, P&#xf6;hlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78:779&#x2013;784. doi: 10.1016/j.molcel.2020.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31&#x2013;55. doi: 10.1007/3-540-26765-4_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/3-540-26765-4_2</ArticleId><ArticleId IdType="pmc">PMC7121018</ArticleId><ArticleId IdType="pubmed">15609508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Lee J-Y, Yang J-S, Kim JW, Kim VN, et al. The architecture of SARS-CoV-2 transcriptome. Cell. 2020;181:914&#x2013;921. doi: 10.1016/j.cell.2020.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.011</ArticleId><ArticleId IdType="pmc">PMC7179501</ArticleId><ArticleId IdType="pubmed">32330414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sola I, Almaz&#xe1;n F, Z&#xfa;&#xf1;iga S, Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annu Rev Virol. 2015;2:265&#x2013;288. doi: 10.1146/annurev-virology-100114-055218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-100114-055218</ArticleId><ArticleId IdType="pmc">PMC6025776</ArticleId><ArticleId IdType="pubmed">26958916</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, et al. The coding capacity of SARS-CoV-2. Nature. 2021;589:125&#x2013;130. doi: 10.1038/s41586-020-2739-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2739-1</ArticleId><ArticleId IdType="pubmed">32906143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antiviral Res. 2018;149:58&#x2013;74. doi: 10.1016/j.antiviral.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7113668</ArticleId><ArticleId IdType="pubmed">29128390</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lin D, Sun X, Curth U, Drosten C, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x3b1;-ketoamide inhibitors. Science. 2020;368:409&#x2013;412. doi: 10.1126/science.abb3405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3405</ArticleId><ArticleId IdType="pmc">PMC7164518</ArticleId><ArticleId IdType="pubmed">32198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott BM, Lacasse V, Blom DG, Tonner PD, Blom NS. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome. BMC Genom Data. 2022;23:25. doi: 10.1186/s12863-022-01044-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12863-022-01044-y</ArticleId><ArticleId IdType="pmc">PMC8977440</ArticleId><ArticleId IdType="pubmed">35379171</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020;369:1249&#x2013;1255. doi: 10.1126/science.abc8665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, et al. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020;27:1094. doi: 10.1038/s41594-020-00533-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00533-x</ArticleId><ArticleId IdType="pmc">PMC7574671</ArticleId><ArticleId IdType="pubmed">33082564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani W, Huang C, Narayanan K, Lokugamage KG, Makino S. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat Struct Mol Biol. 2009;16:1134&#x2013;1140. doi: 10.1038/nsmb.1680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1680</ArticleId><ArticleId IdType="pmc">PMC2784181</ArticleId><ArticleId IdType="pubmed">19838190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakavandi S, Zare I, VaezJalali M, Dadashi M, Azarian M, et al. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Commun Signal. 2023;21:110. doi: 10.1186/s12964-023-01104-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-023-01104-5</ArticleId><ArticleId IdType="pmc">PMC10183699</ArticleId><ArticleId IdType="pubmed">37189112</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya R, Kumari S, Pandey B, Mistry H, Bihani SC, et al. Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2021;433:166725. doi: 10.1016/j.jmb.2020.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.11.024</ArticleId><ArticleId IdType="pmc">PMC7685130</ArticleId><ArticleId IdType="pubmed">33245961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Yan L, Huang Y, Liu F, Zhao Y, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779&#x2013;782. doi: 10.1126/science.abb7498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7498</ArticleId><ArticleId IdType="pmc">PMC7164392</ArticleId><ArticleId IdType="pubmed">32277040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchdoerfer RN, Ward AB. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 2019;10:2342. doi: 10.1038/s41467-019-10280-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10280-3</ArticleId><ArticleId IdType="pmc">PMC6538669</ArticleId><ArticleId IdType="pubmed">31138817</ArticleId></ArticleIdList></Reference><Reference><Citation>Konkolova E, Klima M, Nencka R, Boura E. Structural analysis of the putative SARS-CoV-2 primase complex. J Struct Biol. 2020;211:107548. doi: 10.1016/j.jsb.2020.107548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2020.107548</ArticleId><ArticleId IdType="pmc">PMC7289108</ArticleId><ArticleId IdType="pubmed">32535228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wu L, Shaw N, Gao Y, Wang J, et al. Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proc Natl Acad Sci U S A. 2015;112:9436&#x2013;9441. doi: 10.1073/pnas.1508686112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508686112</ArticleId><ArticleId IdType="pmc">PMC4522806</ArticleId><ArticleId IdType="pubmed">26159422</ArticleId></ArticleIdList></Reference><Reference><Citation>Baddock HT, Brolih S, Yosaatmadja Y, Ratnaweera M, Bielinski M, et al. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. Nucleic Acids Res. 2022;50:1484&#x2013;1500. doi: 10.1093/nar/gkab1303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1303</ArticleId><ArticleId IdType="pmc">PMC8860572</ArticleId><ArticleId IdType="pubmed">35037045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, et al. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol. 2020;94:e01246-20. doi: 10.1128/JVI.01246-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01246-20</ArticleId><ArticleId IdType="pmc">PMC7654266</ArticleId><ArticleId IdType="pubmed">32938769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Malone B, Llewellyn E, Grasso M, Shelton PMM, et al. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex. Cell. 2020;182:1560&#x2013;1573. doi: 10.1016/j.cell.2020.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.033</ArticleId><ArticleId IdType="pmc">PMC7386476</ArticleId><ArticleId IdType="pubmed">32783916</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman JA, Douangamath A, Yadzani S, Yosaatmadja Y, Aimon A, et al. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Nat Commun. 2021;12:4848. doi: 10.1038/s41467-021-25166-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25166-6</ArticleId><ArticleId IdType="pmc">PMC8358061</ArticleId><ArticleId IdType="pubmed">34381037</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang T, Snell KC, Kalia N, Gardezi S, Guo L, et al. Kinetic analysis of RNA cleavage by coronavirus Nsp15 endonuclease: evidence for acid-base catalysis and substrate-dependent metal ion activation. J Biol Chem. 2023;299:104787. doi: 10.1016/j.jbc.2023.104787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.104787</ArticleId><ArticleId IdType="pmc">PMC10158045</ArticleId><ArticleId IdType="pubmed">37149147</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazier MN, Dillard LB, Krahn JM, Perera L, Williams JG, et al. Characterization of SARS2 Nsp15 nuclease activity reveals it&#x2019;s mad about U. Nucleic Acids Res. 2021;49:10136&#x2013;10149. doi: 10.1093/nar/gkab719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab719</ArticleId><ArticleId IdType="pmc">PMC8385992</ArticleId><ArticleId IdType="pubmed">34403466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nencka R, Silhan J, Klima M, Otava T, Kocek H, et al. Coronaviral RNA-methyltransferases: function, structure and inhibition. Nucleic Acids Res. 2022;50:635&#x2013;650. doi: 10.1093/nar/gkab1279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1279</ArticleId><ArticleId IdType="pmc">PMC8789044</ArticleId><ArticleId IdType="pubmed">35018474</ArticleId></ArticleIdList></Reference><Reference><Citation>Krafcikova P, Silhan J, Nencka R, Boura E. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun. 2020;11:3717. doi: 10.1038/s41467-020-17495-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17495-9</ArticleId><ArticleId IdType="pmc">PMC7381658</ArticleId><ArticleId IdType="pubmed">32709887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Ye Q, Singh D, Cao Y, Diedrich JK, et al. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat Commun. 2021;12 doi: 10.1038/s41467-020-20768-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20768-y</ArticleId><ArticleId IdType="pmc">PMC7820290</ArticleId><ArticleId IdType="pubmed">33479198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Zhuang M-W, Han L, Zhang J, Nan M-L, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Signal Transduct Target Ther. 2020;5:299. doi: 10.1038/s41392-020-00438-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00438-7</ArticleId><ArticleId IdType="pmc">PMC7768267</ArticleId><ArticleId IdType="pubmed">33372174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Dong X, Ma R, Wang W, Xiao X, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11:3810. doi: 10.1038/s41467-020-17665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Nomura N, Muramoto Y, Ekimoto T, Uemura T, et al. Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat Commun. 2022;13 doi: 10.1038/s41467-022-32019-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32019-3</ArticleId><ArticleId IdType="pmc">PMC9355944</ArticleId><ArticleId IdType="pubmed">35931673</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques-Pereira C, Pires MN, Gouveia RP, Pereira NN, Caniceiro AB, et al. SARS-CoV-2 membrane protein: from genomic data to structural new insights. Int J Mol Sci. 2022;23:2986. doi: 10.3390/ijms23062986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23062986</ArticleId><ArticleId IdType="pmc">PMC8948900</ArticleId><ArticleId IdType="pubmed">35328409</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Z, Cao Y, Liu W, Li J. The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation. Viruses. 2021;13:1115. doi: 10.3390/v13061115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061115</ArticleId><ArticleId IdType="pmc">PMC8227405</ArticleId><ArticleId IdType="pubmed">34200602</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A, Ib&#xe1;&#xf1;ez de Opakua A, Rankovic M, Zweckstetter M. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nat Commun. 2020;11:6041. doi: 10.1038/s41467-020-19843-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19843-1</ArticleId><ArticleId IdType="pmc">PMC7699647</ArticleId><ArticleId IdType="pubmed">33247108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Gao Y, Liu X, Nie Z, Sun H, et al. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein. BMC Microbiol. 2021;21:58. doi: 10.1186/s12866-021-02107-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-021-02107-3</ArticleId><ArticleId IdType="pmc">PMC7898026</ArticleId><ArticleId IdType="pubmed">33618668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Cheng Y, Zhou H, Sun C, Zhang S. The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol J. 2023;20:6. doi: 10.1186/s12985-023-01968-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-01968-6</ArticleId><ArticleId IdType="pmc">PMC9831023</ArticleId><ArticleId IdType="pubmed">36627683</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, et al. SARS&#x2010;CoV&#x2010;2 nucleocapsid protein phase&#x2010;separates with RNA and with human hnRNPs. The EMBO Journal. 2020;39:24. doi: 10.15252/embj.2020106478.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106478</ArticleId><ArticleId IdType="pmc">PMC7737613</ArticleId><ArticleId IdType="pubmed">33200826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, He G, Yin Q, Zeng L, Ye X, et al. Molecular biology of the SARs-CoV-2 spike protein: a review of current knowledge. J Med Virol. 2021;93:5729&#x2013;5741. doi: 10.1002/jmv.27132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27132</ArticleId><ArticleId IdType="pmc">PMC8427004</ArticleId><ArticleId IdType="pubmed">34125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Yang R, Lee I, Zhang W, Sun J, et al. Characterization of the SARS-CoV-2 E protein: sequence, structure, viroporin, and inhibitors. Protein Sci. 2021;30:1114&#x2013;1130. doi: 10.1002/pro.4075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4075</ArticleId><ArticleId IdType="pmc">PMC8138525</ArticleId><ArticleId IdType="pubmed">33813796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Lv P, Li M, Chen Z, Xin H, et al. SARS-CoV-2 E protein: pathogenesis and potential therapeutic development. Biomed Pharmacother. 2023;159:114242. doi: 10.1016/j.biopha.2023.114242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114242</ArticleId><ArticleId IdType="pmc">PMC9832061</ArticleId><ArticleId IdType="pubmed">36652729</ArticleId></ArticleIdList></Reference><Reference><Citation>Redondo N, Zald&#xed;var-L&#xf3;pez S, Garrido JJ, Montoya M. SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns. Front Immunol. 2021;12:708264. doi: 10.3389/fimmu.2021.708264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708264</ArticleId><ArticleId IdType="pmc">PMC8293742</ArticleId><ArticleId IdType="pubmed">34305949</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtado-Tamayo J, Requena-Platek R, Enjuanes L, Bello-Perez M, Sola I. Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. Front Cell Infect Microbiol. 2023;13:1166839. doi: 10.3389/fcimb.2023.1166839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1166839</ArticleId><ArticleId IdType="pmc">PMC10183600</ArticleId><ArticleId IdType="pubmed">37197199</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Han N, Chen Z, Peng Y, Li L, et al. Compositional diversity and evolutionary pattern of coronavirus accessory proteins. Brief Bioinform. 2021;22:1267&#x2013;1278. doi: 10.1093/bib/bbaa262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa262</ArticleId><ArticleId IdType="pmc">PMC7665327</ArticleId><ArticleId IdType="pubmed">33126244</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY-C, et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid F, Xie Z, Suleman M, Shah A, Khan S, et al. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front Immunol. 2022;13:940756. doi: 10.3389/fimmu.2022.940756.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.940756</ArticleId><ArticleId IdType="pmc">PMC9394213</ArticleId><ArticleId IdType="pubmed">36003396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi M, Shafaati M, Kalantar-Neyestanaki D, Pourghadamyari H, Fani M, et al. The role of SARS-CoV-2 accessory proteins in immune evasion. Biomed Pharmacother. 2022;156:113889. doi: 10.1016/j.biopha.2022.113889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113889</ArticleId><ArticleId IdType="pmc">PMC9574935</ArticleId><ArticleId IdType="pubmed">36265309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408:433&#x2013;439. doi: 10.1038/35044005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35044005</ArticleId><ArticleId IdType="pubmed">11100718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukas J, Lukas C, Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair. 2004;3:997&#x2013;1007. doi: 10.1016/j.dnarep.2004.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2004.03.006</ArticleId><ArticleId IdType="pubmed">15279786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento R, Costa H, Parkhouse RME. Virus manipulation of cell cycle. Protoplasma. 2012;249:519&#x2013;528. doi: 10.1007/s00709-011-0327-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00709-011-0327-9</ArticleId><ArticleId IdType="pubmed">21986922</ArticleId></ArticleIdList></Reference><Reference><Citation>Berk AJ. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene. 2005;24:7673&#x2013;7685. doi: 10.1038/sj.onc.1209040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209040</ArticleId><ArticleId IdType="pubmed">16299528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Israel H, Kleinberger T. Adenovirus and cell cycle control. Front Biosci. 2002;7:d1369&#x2013;95. doi: 10.2741/ben.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/ben</ArticleId><ArticleId IdType="pubmed">11991831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y-F, Sugden AU, Sugden B. Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition. Cell Host Microbe. 2013;14:607&#x2013;618. doi: 10.1016/j.chom.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.11.009</ArticleId><ArticleId IdType="pmc">PMC3995538</ArticleId><ArticleId IdType="pubmed">24331459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth R, Stewart GS, Grand RJ. Productive herpesvirus lytic replication in primary effusion lymphoma cells requires S-phase entry. J Gen Virol. 2020;101:873&#x2013;883. doi: 10.1099/jgv.0.001444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001444</ArticleId><ArticleId IdType="pmc">PMC7641394</ArticleId><ArticleId IdType="pubmed">32501196</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer A, Austin D, Narayanan A, Popova T, Kainulainen M, et al. Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J Biol Chem. 2012;287:7399&#x2013;7410. doi: 10.1074/jbc.M111.296608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.296608</ArticleId><ArticleId IdType="pmc">PMC3293538</ArticleId><ArticleId IdType="pubmed">22223653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioia U, Tavella S, Mart&#xed;nez-Orellana P, Cicio G, Colliva A, et al. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence. Nat Cell Biol. 2023;25:550&#x2013;564. doi: 10.1038/s41556-023-01096-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-023-01096-x</ArticleId><ArticleId IdType="pmc">PMC10104783</ArticleId><ArticleId IdType="pubmed">36894671</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan L, Sun X, Xu L, Chen RA, Liu DX. Coronavirus RNA-dependent RNA polymerase interacts with the p50 regulatory subunit of host DNA polymerase delta and plays a synergistic role with RNA helicase in the induction of DNA damage response and cell cycle arrest in the S phase. Emerg Microbes Infect. 2023;12:e2176008. doi: 10.1080/22221751.2023.2176008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2176008</ArticleId><ArticleId IdType="pmc">PMC9937006</ArticleId><ArticleId IdType="pubmed">36724449</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LH, Huang M, Fang SG, Liu DX. Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase &#x3b4;. J Biol Chem. 2011;286:39546&#x2013;39559. doi: 10.1074/jbc.M111.242206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.242206</ArticleId><ArticleId IdType="pmc">PMC3234778</ArticleId><ArticleId IdType="pubmed">21918226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Chen J, Hu D, Pan P, Liang L, et al. SARS-CoV-2 N protein induces acute kidney injury via Smad3-dependent G1 cell cycle arrest mechanism. Adv Sci. 2022;9:e2103248. doi: 10.1002/advs.202103248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202103248</ArticleId><ArticleId IdType="pmc">PMC8787402</ArticleId><ArticleId IdType="pubmed">34813685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Wang W, Liang L, Chen J, Wei B, et al. Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest. Mol Ther. 2023;31:344&#x2013;361. doi: 10.1016/j.ymthe.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9743779</ArticleId><ArticleId IdType="pubmed">36514292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Gao Y, Liu X, Nie Z, Sun H, et al. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein. BMC Microbiol. 2021;21:58. doi: 10.1186/s12866-021-02107-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-021-02107-3</ArticleId><ArticleId IdType="pmc">PMC7898026</ArticleId><ArticleId IdType="pubmed">33618668</ArticleId></ArticleIdList></Reference><Reference><Citation>Surjit M, Liu B, Chow VTK, Lal SK. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem. 2006;281:10669&#x2013;10681. doi: 10.1074/jbc.M509233200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M509233200</ArticleId><ArticleId IdType="pmc">PMC7995956</ArticleId><ArticleId IdType="pubmed">16431923</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M, Chen Y, Qi S, Shi D, Feng L, et al. A mini-review on cell cycle regulation of coronavirus infection. Front Vet Sci. 2020;7:586826. doi: 10.3389/fvets.2020.586826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2020.586826</ArticleId><ArticleId IdType="pmc">PMC7674852</ArticleId><ArticleId IdType="pubmed">33251267</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182:685&#x2013;712. doi: 10.1016/j.cell.2020.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hong F, Kwon S, Kim SS, Kim DO, et al. Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem Biophys Res Commun. 2002;298:765&#x2013;771. doi: 10.1016/s0006-291x(02)02562-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0006-291x(02)02562-7</ArticleId><ArticleId IdType="pubmed">12419320</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker LL, Piwnica-Worms H. Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science. 1992;257:1955&#x2013;1957. doi: 10.1126/science.1384126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1384126</ArticleId><ArticleId IdType="pubmed">1384126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller PR, Coleman TR, Kumagai A, Dunphy WG. Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science. 1995;270:86&#x2013;90. doi: 10.1126/science.270.5233.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.270.5233.86</ArticleId><ArticleId IdType="pubmed">7569953</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe4;likangas T, Junttila S, Rytk&#xf6;nen KT, Kukkonen-Macchi A, Suomi T, et al. COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts. Front Genet. 2022;13:929887. doi: 10.3389/fgene.2022.929887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.929887</ArticleId><ArticleId IdType="pmc">PMC9388772</ArticleId><ArticleId IdType="pubmed">35991542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittar C, Shrivastava S, Bhanja Chowdhury J, Rahal P, Ray RB. Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm. PLoS One. 2013;8:e62581. doi: 10.1371/journal.pone.0062581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0062581</ArticleId><ArticleId IdType="pmc">PMC3640050</ArticleId><ArticleId IdType="pubmed">23638118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Liu Y, Li K, Hao Z. Roles of p53-mediated host&#x2013;virus interaction in coronavirus infection. IJMS. 2023;24:6371. doi: 10.3390/ijms24076371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076371</ArticleId><ArticleId IdType="pmc">PMC10094438</ArticleId><ArticleId IdType="pubmed">37047343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Grams TR, Bloom DC, Toth Z. Signaling pathway reporter screen with SARS-CoV-2 proteins identifies nsp5 as a repressor of p53 activity. Viruses. 2022;14:1039. doi: 10.3390/v14051039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051039</ArticleId><ArticleId IdType="pmc">PMC9145535</ArticleId><ArticleId IdType="pubmed">35632779</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M, Shi D, Xing X, Qi S, Yang D, et al. coronavirus porcine epidemic diarrhea virus nucleocapsid protein interacts with p53 to induce cell cycle arrest in s-phase and promotes viral replication. J Virol. 2021;95:e0018721. doi: 10.1128/JVI.00187-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00187-21</ArticleId><ArticleId IdType="pmc">PMC8373254</ArticleId><ArticleId IdType="pubmed">34037422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma-Lauer Y, Carbajo-Lozoya J, Hein MY, M&#xfc;ller MA, Deng W, et al. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci U S A. 2016;113:E5192&#x2013;201. doi: 10.1073/pnas.1603435113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1603435113</ArticleId><ArticleId IdType="pmc">PMC5024628</ArticleId><ArticleId IdType="pubmed">27519799</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YS, Hakem A, Hakem R, Chen X. Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis. Mol Cell Biol. 2011;31:3997&#x2013;4006. doi: 10.1128/MCB.05808-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.05808-11</ArticleId><ArticleId IdType="pmc">PMC3187371</ArticleId><ArticleId IdType="pubmed">21791603</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi M, Choi YM, An I-S, Bae S, Jung JH, et al. E3 ligase RCHY1 negatively regulates HDAC2. Biochem Biophys Res Commun. 2020;521:37&#x2013;41. doi: 10.1016/j.bbrc.2019.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.10.049</ArticleId><ArticleId IdType="pubmed">31630802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Zeinab RA, Flores ER, Leng RP. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination. Mol Cancer Res. 2011;9:1780&#x2013;1790. doi: 10.1158/1541-7786.MCR-11-0157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-11-0157</ArticleId><ArticleId IdType="pubmed">21994467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohgaki M, Hakem A, Halaby MJ, Bohgaki T, Li Q, et al. The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover. Cell Death Differ. 2013;20:812&#x2013;822. doi: 10.1038/cdd.2013.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.7</ArticleId><ArticleId IdType="pmc">PMC3647240</ArticleId><ArticleId IdType="pubmed">23449389</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent EMN, Sofianatos Y, Komarova A, Gimeno J-P, Tehrani PS, et al. Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms. Syst Biol. 2020 doi: 10.1101/2020.08.28.272955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.28.272955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H, Ma C, Peng H, Zhang B, Zhou L, et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol Direct. 2021;16:20. doi: 10.1186/s13062-021-00305-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-021-00305-7</ArticleId><ArticleId IdType="pmc">PMC8530504</ArticleId><ArticleId IdType="pubmed">34674770</ArticleId></ArticleIdList></Reference><Reference><Citation>Basaran MM, Hazar M, Ayd&#x131;n M, Uzu&#x11f; G, &#xd6;zdo&#x11f;an &#x130;, et al. Effects of COVID-19 disease on DNA damage, oxidative stress and immune responses. Toxics. 2023;11:386. doi: 10.3390/toxics11040386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxics11040386</ArticleId><ArticleId IdType="pmc">PMC10145820</ArticleId><ArticleId IdType="pubmed">37112613</ArticleId></ArticleIdList></Reference><Reference><Citation>Gain C, Song S, Angtuaco T, Satta S, Kelesidis T. The role of oxidative stress in the pathogenesis of infections with coronaviruses. Front Microbiol. 2022;13:1111930. doi: 10.3389/fmicb.2022.1111930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1111930</ArticleId><ArticleId IdType="pmc">PMC9880066</ArticleId><ArticleId IdType="pubmed">36713204</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhail S, Zajac J, Fossum C, Lowater H, McCracken C, et al. Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review. Protein J. 2020;39:644&#x2013;656. doi: 10.1007/s10930-020-09935-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10930-020-09935-8</ArticleId><ArticleId IdType="pmc">PMC7587547</ArticleId><ArticleId IdType="pubmed">33106987</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn JY, Zhang Y, Wu Y, Cannesson M, Cai H. Therapeutic application of estrogen for COVID-19: attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells. Redox Biol. 2021;46:102099. doi: 10.1016/j.redox.2021.102099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102099</ArticleId><ArticleId IdType="pmc">PMC8372492</ArticleId><ArticleId IdType="pubmed">34509916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hati S, Bhattacharyya S. Impact of thiol-disulfide balance on the binding of covid-19 spike protein with angiotensin-converting enzyme 2 receptor. ACS Omega. 2020;5:16292&#x2013;16298. doi: 10.1021/acsomega.0c02125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.0c02125</ArticleId><ArticleId IdType="pmc">PMC7346263</ArticleId><ArticleId IdType="pubmed">32656452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fossum CJ, Laatsch BF, Lowater HR, Narkiewicz-Jodko AW, Lonzarich L, et al. Pre-existing oxidative stress creates a docking-ready conformation of the SARS-CoV-2 receptor-binding domain. ACS Bio Med Chem Au. 2022;2:84&#x2013;93. doi: 10.1021/acsbiomedchemau.1c00040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsbiomedchemau.1c00040</ArticleId><ArticleId IdType="pmc">PMC8631169</ArticleId><ArticleId IdType="pubmed">37155555</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen I-Y, Moriyama M, Chang M-F, Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol. 2019;10:50. doi: 10.3389/fmicb.2019.00050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00050</ArticleId><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, et al. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang J, Wang L, Aliyari S, Cheng G. SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1. Cell Mol Immunol. 2022;19:872&#x2013;882. doi: 10.1038/s41423-022-00887-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00887-w</ArticleId><ArticleId IdType="pmc">PMC9217730</ArticleId><ArticleId IdType="pubmed">35732914</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Hussain Alsayed HA, Alsafar H, et al. Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection. Free Radic Biol Med. 2021;172:688&#x2013;698. doi: 10.1016/j.freeradbiomed.2021.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8233550</ArticleId><ArticleId IdType="pubmed">34186206</ArticleId></ArticleIdList></Reference><Reference><Citation>Berquist BR, Wilson DM., III Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Letters. 2012;327:61&#x2013;72. doi: 10.1016/j.canlet.2012.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2012.02.001</ArticleId><ArticleId IdType="pmc">PMC3389563</ArticleId><ArticleId IdType="pubmed">22353689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente L, Mart&#xed;n MM, Gonz&#xe1;lez-Rivero AF, P&#xe9;rez-Cejas A, C&#xe1;ceres JJ, et al. DNA and RNA oxidative damage and mortality of patients With COVID-19. Am J Med Sci. 2021;361:585&#x2013;590. doi: 10.1016/j.amjms.2021.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2021.02.012</ArticleId><ArticleId IdType="pmc">PMC7884223</ArticleId><ArticleId IdType="pubmed">33600784</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen MB, Huse C, de Sousa MML, Murphy SL, Sarno A, et al. DNA repair mechanisms are activated in circulating lymphocytes of hospitalized covid-19 patients. J Inflamm Res. 2022;15:6629&#x2013;6644. doi: 10.2147/JIR.S379331.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S379331</ArticleId><ArticleId IdType="pmc">PMC9741826</ArticleId><ArticleId IdType="pubmed">36514358</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakadia BM, Boni BOO, Ahmed AAQ, Yang G. The impact of oxidative stress damage induced by the environmental stressors on COVID-19. Life Sciences. 2021;264:118653. doi: 10.1016/j.lfs.2020.118653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118653</ArticleId><ArticleId IdType="pmc">PMC7586125</ArticleId><ArticleId IdType="pubmed">33115606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekawy AS, Alaswad Z, Ibrahim AA, Mohamed AA, AlOkda A, et al. The consequences of viral infection on host DNA damage response: a focus on SARS-CoVs. J Genet Eng Biotechnol. 2022;20:104. doi: 10.1186/s43141-022-00388-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43141-022-00388-3</ArticleId><ArticleId IdType="pmc">PMC9277982</ArticleId><ArticleId IdType="pubmed">35829826</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor J, Deutsch J, Whitaker A, Lamkin EN, March A, et al. SARS-CoV-2 triggers DNA damage response in Vero E6 cells. Biochem Biophys Res Commun. 2021;579:141&#x2013;145. doi: 10.1016/j.bbrc.2021.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.09.024</ArticleId><ArticleId IdType="pmc">PMC8440005</ArticleId><ArticleId IdType="pubmed">34600299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370:6521. doi: 10.1126/science.abe9403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9403</ArticleId><ArticleId IdType="pmc">PMC7808408</ArticleId><ArticleId IdType="pubmed">33060197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers JM, Ramanathan M, Shanderson RL, Beck A, Donohue L, et al. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation. PLoS Pathog. 2021;17:e1009412. doi: 10.1371/journal.ppat.1009412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009412</ArticleId><ArticleId IdType="pmc">PMC8513853</ArticleId><ArticleId IdType="pubmed">34597346</ArticleId></ArticleIdList></Reference><Reference><Citation>Samavarchi-Tehrani P, Abdouni H, Knight JDR, Astori A, Samson R, et al. A SARS-CoV-2 &#x2013; host proximity interactome. bioRxiv. 2020 doi: 10.1101/2020.09.03.282103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.03.282103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, et al. A comprehensive SARS-CoV-2&#x2013;human protein&#x2013;protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. Nat Biotechnol. 2023;41:128&#x2013;139. doi: 10.1038/s41587-022-01474-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01474-0</ArticleId><ArticleId IdType="pmc">PMC9851973</ArticleId><ArticleId IdType="pubmed">36217030</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Guo M, Tian X, Wang X, Yang X, et al. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med. 2021;2:99&#x2013;112. doi: 10.1016/j.medj.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Huuskonen S, Laitinen T, Redchuk T, Bogacheva M, et al. SARS-CoV-2-host proteome interactions for antiviral drug discovery. Mol Syst Biol. 2021;17:e10396. doi: 10.15252/msb.202110396.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202110396</ArticleId><ArticleId IdType="pmc">PMC8552907</ArticleId><ArticleId IdType="pubmed">34709727</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Tang Z, Fan W, Wang X, Huang L, et al. Atlas of interactions between SARS-CoV-2 macromolecules and host proteins. Cell Insight. 2023;2:100068. doi: 10.1016/j.cellin.2022.100068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellin.2022.100068</ArticleId><ArticleId IdType="pmc">PMC9670597</ArticleId><ArticleId IdType="pubmed">37192911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D-K, Weller B, Lin C-W, Sheykhkarimli D, Knapp JJ, et al. A proteome-scale map of the SARS-CoV-2-human contactome. Nat Biotechnol. 2023;41:140&#x2013;149. doi: 10.1038/s41587-022-01475-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01475-z</ArticleId><ArticleId IdType="pmc">PMC9849141</ArticleId><ArticleId IdType="pubmed">36217029</ArticleId></ArticleIdList></Reference><Reference><Citation>Duhan N, Kaundal R. HuCoPIA: an atlas of human vs. SARS-CoV-2 interactome and the comparative analysis with other Coronaviridae family viruses. Viruses. 2023;15:492. doi: 10.3390/v15020492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020492</ArticleId><ArticleId IdType="pmc">PMC9962590</ArticleId><ArticleId IdType="pubmed">36851706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas E, Golemis EA, Arora S. POLD1: central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene. 2016;590:128&#x2013;141. doi: 10.1016/j.gene.2016.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.06.031</ArticleId><ArticleId IdType="pmc">PMC4969162</ArticleId><ArticleId IdType="pubmed">27320729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipskaia L, Maisonnasse P, Fouillade C, Sencio V, Pascal Q, et al. Evidence that SARS-CoV-2 induces lung Cell senescence: potential impact on COVID-19 lung disease. Am J Respir Cell Mol Biol. 2022;66:107&#x2013;111. doi: 10.1165/rcmb.2021-0205LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2021-0205LE</ArticleId><ArticleId IdType="pmc">PMC8803362</ArticleId><ArticleId IdType="pubmed">34648725</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo F, Walters K-A, Xiao Y, Sheng Z-M, Scherler K, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med. 2021;13:620. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanakkanthara A, Huntoon CJ, Hou X, Zhang M, Heinzen EP, et al. ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer. Nat Commun. 2019;10 doi: 10.1038/s41467-019-12610-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12610-x</ArticleId><ArticleId IdType="pmc">PMC6789141</ArticleId><ArticleId IdType="pubmed">31604914</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia G, Jr Sharma A, Ramaiah A, Sen C, Purkayastha A, et al. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Reports. 2021;35:108940. doi: 10.1016/j.celrep.2021.108940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108940</ArticleId><ArticleId IdType="pmc">PMC7969873</ArticleId><ArticleId IdType="pubmed">33784499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui C, Xiao T, Zhang S, Zeng H, Zheng Y, et al. SARS-CoV-2 NSP13 inhibits type I IFN production by degradation of TBK1 via p62-dependent selective autophagy. J Immunol. 2022;208:753&#x2013;761. doi: 10.4049/jimmunol.2100684.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100684</ArticleId><ArticleId IdType="pubmed">34996837</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, et al. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One. 2021;16:e0253089. doi: 10.1371/journal.pone.0253089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253089</ArticleId><ArticleId IdType="pmc">PMC8224853</ArticleId><ArticleId IdType="pubmed">34166398</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelini F, Pitchiaya S, Vitelli V, Sharma S, Gioia U, et al. Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks. Nat Cell Biol. 2017;19:1400&#x2013;1411. doi: 10.1038/ncb3643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3643</ArticleId><ArticleId IdType="pmc">PMC5714282</ArticleId><ArticleId IdType="pubmed">29180822</ArticleId></ArticleIdList></Reference><Reference><Citation>Pessina F, Giavazzi F, Yin Y, Gioia U, Vitelli V, et al. Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors. Nat Cell Biol. 2019;21:1286&#x2013;1299. doi: 10.1038/s41556-019-0392-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0392-4</ArticleId><ArticleId IdType="pmc">PMC6859070</ArticleId><ArticleId IdType="pubmed">31570834</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A, Ib&#xe1;&#xf1;ez de Opakua A, Rankovic M, Zweckstetter M. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. Nat Commun. 2020;11:6041. doi: 10.1038/s41467-020-19843-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19843-1</ArticleId><ArticleId IdType="pmc">PMC7699647</ArticleId><ArticleId IdType="pubmed">33247108</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, et al. SARS&#x2010;CoV&#x2010;2 nucleocapsid protein phase&#x2010;separates with RNA and with human hnRNPs. EMBO J. 2020;39:24. doi: 10.15252/embj.2020106478.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106478</ArticleId><ArticleId IdType="pmc">PMC7737613</ArticleId><ArticleId IdType="pubmed">33200826</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtin N, B&#xe1;nyai K, Thaventhiran J, Le Quesne J, Helyes Z, et al. Repositioning PARP inhibitors for SARS&#x2010;CoV&#x2010;2 infection(COVID&#x2010;19); a new multi&#x2010;pronged therapy for acute respiratory distress syndrome? Br J Pharmacol. 2020;177:3635&#x2013;3645. doi: 10.1111/bph.15137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15137</ArticleId><ArticleId IdType="pmc">PMC7280733</ArticleId><ArticleId IdType="pubmed">32441764</ArticleId></ArticleIdList></Reference><Reference><Citation>Heer CD, Sanderson DJ, Voth LS, Alhammad YMO, Schmidt MS, et al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. J Biol Chem. 2020;295:17986&#x2013;17996. doi: 10.1074/jbc.RA120.015138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015138</ArticleId><ArticleId IdType="pmc">PMC7834058</ArticleId><ArticleId IdType="pubmed">33051211</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone NE, Jaramillo SA, Jones AN, Vazquez AJ, Martz M, et al. Stenoparib, an inhibitor of cellular poly(ADP-Ribose) polymerase, blocks replication of the SARS-CoV-2 and HCoV-NL63 human coronaviruses In Vitro . mBio. 2021;12:e03495-20. doi: 10.1128/mBio.03495-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03495-20</ArticleId><ArticleId IdType="pmc">PMC7845641</ArticleId><ArticleId IdType="pubmed">33468703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascal JM. The comings and goings of PARP-1 in response to DNA damage. DNA Repair. 2018;71:177&#x2013;182. doi: 10.1016/j.dnarep.2018.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2018.08.022</ArticleId><ArticleId IdType="pmc">PMC6637744</ArticleId><ArticleId IdType="pubmed">30177435</ArticleId></ArticleIdList></Reference><Reference><Citation>Langelier MF, Eisemann T, Riccio AA, Pascal JM. PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification. Curr Opin Struct Biol. 2018;53:187&#x2013;198. doi: 10.1016/j.sbi.2018.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2018.11.002</ArticleId><ArticleId IdType="pmc">PMC6687463</ArticleId><ArticleId IdType="pubmed">30481609</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MS. Interplay between compartmentalized NAD + synthesis and consumption: A focus on the PARP family. Genes Dev. 2020;34:254&#x2013;262. doi: 10.1101/gad.335109.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335109.119</ArticleId><ArticleId IdType="pmc">PMC7050480</ArticleId><ArticleId IdType="pubmed">32029457</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampogu S, Jung TS, Ha MW, Lee KW. Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors. Sci Rep. 2023;13 doi: 10.1038/s41598-023-36342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36342-7</ArticleId><ArticleId IdType="pmc">PMC10310815</ArticleId><ArticleId IdType="pubmed">37386052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Kandula S, Huynh M, Greene SK, Van Wye G, et al. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. Lancet Infect Dis. 2021;21:203&#x2013;212. doi: 10.1016/S1473-3099(20)30769-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30769-6</ArticleId><ArticleId IdType="pmc">PMC7572090</ArticleId><ArticleId IdType="pubmed">33091374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D, Tentolouris A, Eleftheriadou I, Tentolouris N. Telomere length, epidemiology and pathogenesis of severe COVID-19. Eur J Clin Invest. 2020;50:e13376. doi: 10.1111/eci.13376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13376</ArticleId><ArticleId IdType="pmc">PMC7435533</ArticleId><ArticleId IdType="pubmed">32880939</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviv A. Telomeres and COVID-19. FASEB J. 2020;34:7247&#x2013;7252. doi: 10.1096/fj.202001025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001025</ArticleId><ArticleId IdType="pmc">PMC7276714</ArticleId><ArticleId IdType="pubmed">32427393</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, Sanaie S, Roudbari F, Sabzevari T, Sohrabifar N, et al. Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity. Gene. 2022;811:146069. doi: 10.1016/j.gene.2021.146069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2021.146069</ArticleId><ArticleId IdType="pmc">PMC8634871</ArticleId><ArticleId IdType="pubmed">34848322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Vazquez R, Gu&#xed;o-Carri&#xf3;n A, Zapatero-Gaviria A, Mart&#xed;nez P, Blasco MA. Shorter telomere lengths in patients with severe COVID-19 disease. Aging. 2021;13:1&#x2013;15. doi: 10.18632/aging.202463.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.202463</ArticleId><ArticleId IdType="pmc">PMC7835063</ArticleId><ArticleId IdType="pubmed">33428591</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Zhang F, Shi Y, Chen Y, Shi B, et al. Causal association of epigenetic aging and COVID-19 severity and susceptibility: a bidirectional Mendelian randomization study. Front Med. 2022;9:989950. doi: 10.3389/fmed.2022.989950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.989950</ArticleId><ArticleId IdType="pmc">PMC9538153</ArticleId><ArticleId IdType="pubmed">36213637</ArticleId></ArticleIdList></Reference><Reference><Citation>Haridoss M, Ayyasamy L, Bagepally BS. Is COVID-19 severity associated with telomere length? A systematic review and meta-analysis. Virus Genes. 2023;59:489&#x2013;498. doi: 10.1007/s11262-023-02010-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-023-02010-1</ArticleId><ArticleId IdType="pmc">PMC10234232</ArticleId><ArticleId IdType="pubmed">37261700</ArticleId></ArticleIdList></Reference><Reference><Citation>Benetos A, Lai T-P, Toupance S, Labat C, Verhulst S, et al. The nexus between telomere length and lymphocyte count in seniors hospitalized with COVID-19. J Gerontol A Biol Sci Med Sci. 2021;76:e97&#x2013;e101. doi: 10.1093/gerona/glab026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glab026</ArticleId><ArticleId IdType="pmc">PMC7929343</ArticleId><ArticleId IdType="pubmed">33528568</ArticleId></ArticleIdList></Reference><Reference><Citation>McGroder CF, Zhang D, Choudhury MA, Salvatore MM, D&#x2019;Souza BM, et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax. 2021;76:1242&#x2013;1245. doi: 10.1136/thoraxjnl-2021-217031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217031</ArticleId><ArticleId IdType="pmc">PMC8103561</ArticleId><ArticleId IdType="pubmed">33927016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepe S, Rossiello F, Cancila V, Iannelli F, Matti V, et al. DNA damage response at telomeres boosts the transcription of SARS&#x2010;CoV&#x2010;2 receptor ACE2 during aging. EMBO Reports. 2022;23 doi: 10.15252/embr.202153658.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153658</ArticleId><ArticleId IdType="pmc">PMC8811650</ArticleId><ArticleId IdType="pubmed">34854526</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong AS, Stern JL, Sfeir A, Kartawinata M, de Lange T, et al. ATM and ATR signaling regulate the recruitment of human telomerase to telomeres. Cell Reports. 2015;13:1633&#x2013;1646. doi: 10.1016/j.celrep.2015.10.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.10.041</ArticleId><ArticleId IdType="pmc">PMC4662887</ArticleId><ArticleId IdType="pubmed">26586433</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512&#x2013;522. doi: 10.1038/nrc2440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2440</ArticleId><ArticleId IdType="pubmed">18574463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813&#x2013;827. doi: 10.1016/j.cell.2019.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.10.005</ArticleId><ArticleId IdType="pubmed">31675495</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, et al. COVID-19 and cellular senescence. Nat Rev Immunol. 2023;23:251&#x2013;263. doi: 10.1038/s41577-022-00785-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00785-2</ArticleId><ArticleId IdType="pmc">PMC9533263</ArticleId><ArticleId IdType="pubmed">36198912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599:283&#x2013;289. doi: 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, et al. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J. 2022;60:2102951. doi: 10.1183/13993003.02951-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02951-2021</ArticleId><ArticleId IdType="pmc">PMC8796696</ArticleId><ArticleId IdType="pubmed">35086840</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe5;rtensson CU, Priesnitz C, Song J, Ellenrieder L, Doan KN, et al. Mitochondrial protein translocation-associated degradation. Nature. 2019;569:679&#x2013;683. doi: 10.1038/s41586-019-1227-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1227-y</ArticleId><ArticleId IdType="pubmed">31118508</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C, Liu Z, Zhu Y, Lu J, Ge C, et al. SARS-CoV-2 causes mitochondrial dysfunction and mitophagy impairment. Front Microbiol. 2021;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Hou P, Ma W, Wang X, Wang H, et al. SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol. 2022;19:67&#x2013;78. doi: 10.1038/s41423-021-00807-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00807-4</ArticleId><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, Wilkins D, Garzino-Demo A, et al. Biological mechanisms underpinning the development of long COVID. iScience. 2023;26:106935. doi: 10.1016/j.isci.2023.106935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106935</ArticleId><ArticleId IdType="pmc">PMC10193768</ArticleId><ArticleId IdType="pubmed">37265584</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R, Shunmugam L, Naidoo K, Abdool Karim SS, Wilkins D, et al. Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol. 2023;14:1117464. doi: 10.3389/fimmu.2023.1117464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, et al. A review of persistent post-COVID syndrome (PPCS) Clin Rev Allergy Immunol. 2023;64:66&#x2013;74. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB. RECOVER mechanistic pathways task force. viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12 doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, O&#x2019;Farrelly C, Tancevski I, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28:879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q, Fan L, Liu W, Li J, Yue J, et al. Direct evidence of active SARS-CoV-2 replication in the intestine. Clin Infect Dis. 2021;73:361&#x2013;366. doi: 10.1093/cid/ciaa925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa925</ArticleId><ArticleId IdType="pmc">PMC7454471</ArticleId><ArticleId IdType="pubmed">32638022</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Q, Feng Z, Diao B, Tu C, Qiao Q, et al. SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs. Front Immunol. 2021;12:661052. doi: 10.3389/fimmu.2021.661052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.661052</ArticleId><ArticleId IdType="pmc">PMC8113960</ArticleId><ArticleId IdType="pubmed">33995382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar-Rodr&#xed;guez A, Padilla-Gonz&#xe1;lez A, Rivera-Toledo E. Coronavirus persistence in human respiratory tract and cell culture: an overview. Braz J Infect Dis. 2021;25:101632. doi: 10.1016/j.bjid.2021.101632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2021.101632</ArticleId><ArticleId IdType="pmc">PMC8486621</ArticleId><ArticleId IdType="pubmed">34627782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Wang X, Lv T. Prolonged SARS-CoV-2 RNA shedding: not a rare phenomenon. J Med Virol. 2020;92:2286&#x2013;2287. doi: 10.1002/jmv.25952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25952</ArticleId><ArticleId IdType="pmc">PMC7267144</ArticleId><ArticleId IdType="pubmed">32347980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB. RECOVER mechanistic pathways task force. viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12 doi: 10.7554/eLife.8601.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.8601</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Hu J, Liu L, Chen R, Wang M, et al. SARS-CoV-2 causes acute kidney injury by directly infecting renal tubules. Front Cell Dev Biol. 2021;9:664868. doi: 10.3389/fcell.2021.664868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.664868</ArticleId><ArticleId IdType="pmc">PMC8201778</ArticleId><ArticleId IdType="pubmed">34136484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci USA. 2021;118:21. doi: 10.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs E, Ward W, Rey S, Law D, Nelson K, et al. Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing. Proc Natl Acad Sci U S A. 2021;118:44. doi: 10.1073/pnas.2113065118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113065118</ArticleId><ArticleId IdType="pmc">PMC8612208</ArticleId><ArticleId IdType="pubmed">34702741</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry R, Gifford RJ, Lytras S, Ray SC, Coin LJM. No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues. Proc Natl Acad Sci U S A. 2021;118:33. doi: 10.1073/pnas.2109066118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109066118</ArticleId><ArticleId IdType="pmc">PMC8379926</ArticleId><ArticleId IdType="pubmed">34344759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S, Kawanaka M, Kamei A, Izumi A, Nakata K, et al. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal. 2004;6:19&#x2013;24. doi: 10.1089/152308604771978318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/152308604771978318</ArticleId><ArticleId IdType="pubmed">14713333</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, et al. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol. 2006;21:1821&#x2013;1825. doi: 10.1111/j.1440-1746.2006.04420.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2006.04420.x</ArticleId><ArticleId IdType="pubmed">17074020</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinati F, Cardin R, Bortolami M, Burra P, Russo FP, et al. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat. 2007;14:821&#x2013;829. doi: 10.1111/j.1365-2893.2007.00878.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2893.2007.00878.x</ArticleId><ArticleId IdType="pubmed">18070284</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida K, Cheng KT-N, Sung VM-H, Shimodaira S, Lindsay KL, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A. 2004;101:4262&#x2013;4267. doi: 10.1073/pnas.0303971101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0303971101</ArticleId><ArticleId IdType="pmc">PMC384729</ArticleId><ArticleId IdType="pubmed">14999097</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida K, Cheng KT-H, Sung VM-H, Lee KJ, Levine AM, et al. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol. 2004;78:8835&#x2013;8843. doi: 10.1128/JVI.78.16.8835-8843.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.16.8835-8843.2004</ArticleId><ArticleId IdType="pmc">PMC479064</ArticleId><ArticleId IdType="pubmed">15280491</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida T, Takahashi T, Itoh T, Hirayama M, Morita T, et al. Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J Gastroenterol. 2007;13:5403&#x2013;5407. doi: 10.3748/wjg.v13.i40.5403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v13.i40.5403</ArticleId><ArticleId IdType="pmc">PMC4171337</ArticleId><ArticleId IdType="pubmed">17879417</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida K, Cheng KT-H, Lai C-K, Jeng K-S, Sung VM-H, et al. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol. 2006;80:7199&#x2013;7207. doi: 10.1128/JVI.00321-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00321-06</ArticleId><ArticleId IdType="pmc">PMC1489016</ArticleId><ArticleId IdType="pubmed">16809325</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida K, Cheng KTH, Sung VM-H, Levine AM, Foung S, et al. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol. 2006;80:866&#x2013;874. doi: 10.1128/JVI.80.2.866-874.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.2.866-874.2006</ArticleId><ArticleId IdType="pmc">PMC1346849</ArticleId><ArticleId IdType="pubmed">16378988</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs MR, Chouteau P, Lerat H. &#x201c;Liver let die&#x201d;: oxidative DNA damage and hepatotropic viruses. J Gen Virol. 2014;95:991&#x2013;1004. doi: 10.1099/vir.0.059485-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.059485-0</ArticleId><ArticleId IdType="pubmed">24496828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitin PA, Luftig MA. At a crossroads: human DNA tumor viruses and the host DNA damage response. Future Virol. 2011;6:813&#x2013;830. doi: 10.2217/fvl.11.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.11.55</ArticleId><ArticleId IdType="pmc">PMC3171950</ArticleId><ArticleId IdType="pubmed">21927617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardivat Y, Sosnowski P, Tidu A, Westhof E, Eriani G, et al. SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome. Nucleic Acids Res. 2023;51:8677&#x2013;8690. doi: 10.1093/nar/gkad627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad627</ArticleId><ArticleId IdType="pmc">PMC10484668</ArticleId><ArticleId IdType="pubmed">37503833</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, et al. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020;27:1094. doi: 10.1038/s41594-020-00533-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00533-x</ArticleId><ArticleId IdType="pmc">PMC7574671</ArticleId><ArticleId IdType="pubmed">33082564</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020;369:1249&#x2013;1255. doi: 10.1126/science.abc8665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Choi J-H, Dai DL, Luo J, Ladak RJ, et al. SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation. Proc Natl Acad Sci U S A. 2022;119:e2204539119. doi: 10.1073/pnas.2204539119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2204539119</ArticleId><ArticleId IdType="pmc">PMC9371684</ArticleId><ArticleId IdType="pubmed">35878012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Azumaya CM, Moritz M, Pourmal S, Diallo A, et al. CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes. bioRxiv. 2021;2021:2021. doi: 10.1101/2021.05.10.443524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.10.443524</ArticleId><ArticleId IdType="pmc">PMC8132225</ArticleId><ArticleId IdType="pubmed">34013269</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Xue B, Schnicker NJ, Wong L-YR, Meyerholz DK, et al. Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence. Proc Natl Acad Sci USA. 2023;120:31. doi: 10.1073/pnas.2305674120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2305674120</ArticleId><ArticleId IdType="pmc">PMC10400999</ArticleId><ArticleId IdType="pubmed">37487098</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong LA, Lange SM, Dee Cesare V, Matthews SP, Nirujogi RS, et al. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. PLoS One. 2021;16:e0253364. doi: 10.1371/journal.pone.0253364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253364</ArticleId><ArticleId IdType="pmc">PMC8284666</ArticleId><ArticleId IdType="pubmed">34270554</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio. 2013;4:e00524-13. doi: 10.1128/mBio.00524-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00524-13</ArticleId><ArticleId IdType="pmc">PMC3747587</ArticleId><ArticleId IdType="pubmed">23943763</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Qin C, Rao Y, Ngo C, Feng JJ, et al. SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS to evade the innate immune response. mBio. 2021;12:e0233521. doi: 10.1128/mBio.02335-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02335-21</ArticleId><ArticleId IdType="pmc">PMC8546575</ArticleId><ArticleId IdType="pubmed">34544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi S, Guarino AM, Giaquinto L, Polishchuk EV, Santoro M, et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle. Nature. 2022;606:761&#x2013;768. doi: 10.1038/s41586-022-04835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04835-6</ArticleId><ArticleId IdType="pmc">PMC7612910</ArticleId><ArticleId IdType="pubmed">35551511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillen HS, Kokic G, Farnung L, Dienemann C, Tegunov D, et al. Structure of replicating SARS-CoV-2 polymerase. Nature. 2020;584:154&#x2013;156. doi: 10.1038/s41586-020-2368-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2368-8</ArticleId><ArticleId IdType="pubmed">32438371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Wu J, Wang H, Gao Y, Liu Q, et al. Structural basis for RNA replication by the SARS-CoV-2 polymerase. Cell. 2020;182:417&#x2013;428. doi: 10.1016/j.cell.2020.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.034</ArticleId><ArticleId IdType="pmc">PMC7242921</ArticleId><ArticleId IdType="pubmed">32526208</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zheng Y, Zheng S-N, Nan M-L, Han L, et al. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol. 2023;95:e28561. doi: 10.1002/jmv.28561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28561</ArticleId><ArticleId IdType="pubmed">36755358</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zheng S-N, Xiao Y, Nan M-L, Zhang J, et al. SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol. 2023;95:e28680. doi: 10.1002/jmv.28680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28680</ArticleId><ArticleId IdType="pubmed">36929724</ArticleId></ArticleIdList></Reference><Reference><Citation>Park GJ, Osinski A, Hernandez G, Eitson JL, Majumdar A, et al. The mechanism of RNA capping by SARS-CoV-2. Nature. 2022;609:793&#x2013;800. doi: 10.1038/s41586-022-05185-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05185-z</ArticleId><ArticleId IdType="pmc">PMC9492545</ArticleId><ArticleId IdType="pubmed">35944563</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang JS, Mueller JR, Luo E-C, Yee BA, Schafer D, et al. Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions. bioRxiv. 2022:2022.02.21.481223. doi: 10.1101/2022.02.21.481223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.21.481223</ArticleId><ArticleId IdType="pmc">PMC8887137</ArticleId><ArticleId IdType="pubmed">35233578</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Kamand S, Du Plessis M-D, Breen N, Johnson L, Beard S, et al. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2. Proteins. 2022;90:176&#x2013;185. doi: 10.1002/prot.26205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.26205</ArticleId><ArticleId IdType="pmc">PMC8441931</ArticleId><ArticleId IdType="pubmed">34369011</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccio AA, Sullivan ED, Copeland WC. Activation of the SARS-CoV-2 NSP14 3&#x2019;-5&#x2019; exoribonuclease by NSP10 and response to antiviral inhibitors. J Biol Chem. 2022;298:101518. doi: 10.1016/j.jbc.2021.101518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101518</ArticleId><ArticleId IdType="pmc">PMC8685350</ArticleId><ArticleId IdType="pubmed">34942146</ArticleId></ArticleIdList></Reference><Reference><Citation>Klima M, Khalili Yazdi A, Li F, Chau I, Hajian T, et al. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16. Protein Sci. 2022;31:e4395. doi: 10.1002/pro.4395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4395</ArticleId><ArticleId IdType="pmc">PMC9375521</ArticleId><ArticleId IdType="pubmed">36040262</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadhave K, Kumar P, Kumar A, Bhardwaj T, Garg N, et al. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions. Microb Pathog. 2021;158:105041. doi: 10.1016/j.micpath.2021.105041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105041</ArticleId><ArticleId IdType="pmc">PMC8191288</ArticleId><ArticleId IdType="pubmed">34119626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin W, Mao C, Luan X, Shen D-D, Shen Q, et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020;368:1499&#x2013;1504. doi: 10.1126/science.abc1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1560</ArticleId><ArticleId IdType="pmc">PMC7199908</ArticleId><ArticleId IdType="pubmed">32358203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen C-K, Lam J-Y, Wong W-M, Mak L-F, Wang X, et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect. 2020;9:1418&#x2013;1428. doi: 10.1080/22221751.2020.1780953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1780953</ArticleId><ArticleId IdType="pmc">PMC7473193</ArticleId><ArticleId IdType="pubmed">32529952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui C, Xiao T, Zhang S, Zeng H, Zheng Y, et al. SARS-CoV-2 NSP13 inhibits type I IFN production by degradation of TBK1 via p62-dependent selective autophagy. J Immunol. 2022;208:753&#x2013;761. doi: 10.4049/jimmunol.2100684.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100684</ArticleId><ArticleId IdType="pubmed">34996837</ArticleId></ArticleIdList></Reference><Reference><Citation>Imprachim N, Yosaatmadja Y, Newman JA. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res. 2023;51:475&#x2013;487. doi: 10.1093/nar/gkac1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1207</ArticleId><ArticleId IdType="pmc">PMC9841433</ArticleId><ArticleId IdType="pubmed">36546776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan R, Kindler E, Cao L, Zhou Y, Zhang Z, et al. N7-methylation of the coronavirus RNA cap is required for maximal virulence by preventing innate immune recognition. mBio. 2022;13:e0366221. doi: 10.1128/mbio.03662-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03662-21</ArticleId><ArticleId IdType="pmc">PMC8787479</ArticleId><ArticleId IdType="pubmed">35073761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson IM, Frazier MN, Li JL, Randall TA, Stanley RE. Biochemical characterization of emerging SARS-CoV-2 Nsp15 endoribonuclease variants. J Mol Biol. 2022;434:167796. doi: 10.1016/j.jmb.2022.167796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2022.167796</ArticleId><ArticleId IdType="pmc">PMC9389836</ArticleId><ArticleId IdType="pubmed">35995266</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ A, Wittmann S, Tsukamoto Y, Herrmann A, Deutschmann J, et al. Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction. EMBO Rep. 2022;23:e55648. doi: 10.15252/embr.202255648.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202255648</ArticleId><ArticleId IdType="pmc">PMC9724656</ArticleId><ArticleId IdType="pubmed">36285486</ArticleId></ArticleIdList></Reference><Reference><Citation>Vithani N, Ward MD, Zimmerman MI, Novak B, Borowsky JH, et al. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential. Biophys J. 2021;120:2880&#x2013;2889. doi: 10.1016/j.bpj.2021.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.03.024</ArticleId><ArticleId IdType="pmc">PMC8007187</ArticleId><ArticleId IdType="pubmed">33794150</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829&#x2013;838. doi: 10.1038/s41590-021-00937-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00937-x</ArticleId><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SJ, Shin OS. SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response. Cells. 2021;10:530. doi: 10.3390/cells10030530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030530</ArticleId><ArticleId IdType="pmc">PMC7999926</ArticleId><ArticleId IdType="pubmed">33801464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Xiao F, Hu D, Ge W, Tian M, et al. SARS-CoV-2 nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-&#x3b2; production. Viruses. 2020;13:47. doi: 10.3390/v13010047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010047</ArticleId><ArticleId IdType="pmc">PMC7823417</ArticleId><ArticleId IdType="pubmed">33396605</ArticleId></ArticleIdList></Reference><Reference><Citation>Guruprasad L. Human coronavirus spike protein-host receptor recognition. Prog Biophys Mol Biol. 2021;161:39&#x2013;53. doi: 10.1016/j.pbiomolbio.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7604128</ArticleId><ArticleId IdType="pubmed">33137344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Y, Wu L, Niu S, Song C, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894&#x2013;904. doi: 10.1016/j.cell.2020.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7144619</ArticleId><ArticleId IdType="pubmed">32275855</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Akinyemi IA, Chitre SA, Loeb JC, Lednicky JA, et al. SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway. Virology. 2022;568:13&#x2013;22. doi: 10.1016/j.virol.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8762580</ArticleId><ArticleId IdType="pubmed">35066302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad N, Laurent-Rolle M, Ahmed WS, Hsu JC-C, Mitchell SM, et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc Natl Acad Sci USA. 2023;120 doi: 10.1073/pnas.2208525120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2208525120</ArticleId><ArticleId IdType="pmc">PMC9910621</ArticleId><ArticleId IdType="pubmed">36574644</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o-Rodriguez C, Honrubia JM, Guti&#xe9;rrez-&#xc1;lvarez J, DeDiego ML, Nieto-Torres JL, et al. Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. mBio. 2018;9:e02325-17. doi: 10.1128/mBio.02325-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02325-17</ArticleId><ArticleId IdType="pmc">PMC5964350</ArticleId><ArticleId IdType="pubmed">29789363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern DM, Sorum B, Mali SS, Hoel CM, Sridharan S, et al. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs. Nat Struct Mol Biol. 2021;28:573&#x2013;582. doi: 10.1038/s41594-021-00619-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00619-0</ArticleId><ArticleId IdType="pmc">PMC8772433</ArticleId><ArticleId IdType="pubmed">34158638</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu K, Yuen K, Castano&#x2010;Rodriguez C, Ye Z, Yeung M, et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3&#x2010;dependent ubiquitination of ASC. FASEB J. 2019;33:8865&#x2013;8877. doi: 10.1096/fj.201802418R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802418R</ArticleId><ArticleId IdType="pmc">PMC6662968</ArticleId><ArticleId IdType="pubmed">31034780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y, Mou L, Long Q, Deng D, Hu R, et al. SARS-CoV-2 ORF3a positively regulates NF-&#x3ba;B activity by enhancing IKK&#x3b2;-NEMO interaction. Virus Res. 2023;328:199086. doi: 10.1016/j.virusres.2023.199086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2023.199086</ArticleId><ArticleId IdType="pmc">PMC10009424</ArticleId><ArticleId IdType="pubmed">36894068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Shu T, Wu D, Mu J, Wang C, et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol. 2020;17:881&#x2013;883. doi: 10.1038/s41423-020-0485-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0485-9</ArticleId><ArticleId IdType="pmc">PMC7301057</ArticleId><ArticleId IdType="pubmed">32555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno Y, Kimura I, Uriu K, Fukushi M, Irie T, et al. SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. 2020;32:108185. doi: 10.1016/j.celrep.2020.108185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108185</ArticleId><ArticleId IdType="pmc">PMC7473339</ArticleId><ArticleId IdType="pubmed">32941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Miorin L, Kehrer T, Sanchez-Aparicio MT, Zhang K, Cohen P, et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U S A. 2020;117:28344&#x2013;28354. doi: 10.1073/pnas.2016650117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016650117</ArticleId><ArticleId IdType="pmc">PMC7668094</ArticleId><ArticleId IdType="pubmed">33097660</ArticleId></ArticleIdList></Reference><Reference><Citation>Addetia A, Lieberman NAP, Phung Q, Hsiang T-Y, Xie H, et al. SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98. mBio. 2021;12:e00065-21. doi: 10.1128/mBio.00065-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00065-21</ArticleId><ArticleId IdType="pmc">PMC8092196</ArticleId><ArticleId IdType="pubmed">33849972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-G, Huang W, Lee H, van de Leemput J, Kane MA, et al. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by selinexor. Cell Biosci. 2021;11:58. doi: 10.1186/s13578-021-00568-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00568-7</ArticleId><ArticleId IdType="pmc">PMC7993076</ArticleId><ArticleId IdType="pubmed">33766124</ArticleId></ArticleIdList></Reference><Reference><Citation>Su CM, Wang L, Yoo D. Activation of NF-&#x3ba;B and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci Rep. 2021;11:13464. doi: 10.1038/s41598-021-92941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92941-2</ArticleId><ArticleId IdType="pmc">PMC8242070</ArticleId><ArticleId IdType="pubmed">34188167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou P, Wang X, Wang H, Wang T, Yu Z, et al. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy. 2023;19:551&#x2013;569. doi: 10.1080/15548627.2022.2084686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2084686</ArticleId><ArticleId IdType="pmc">PMC9851267</ArticleId><ArticleId IdType="pubmed">35670302</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Garc&#xed;a T, Fern&#xe1;ndez-Rodr&#xed;guez R, Redondo N, de Lucas-Rius A, Zald&#xed;var-L&#xf3;pez S, et al. Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b. iScience. 2022;25:105444. doi: 10.1016/j.isci.2022.105444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105444</ArticleId><ArticleId IdType="pmc">PMC9597514</ArticleId><ArticleId IdType="pubmed">36310646</ArticleId></ArticleIdList></Reference><Reference><Citation>Flower TG, Buffalo CZ, Hooy RM, Allaire M, Ren X, et al. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc Natl Acad Sci U S A. 2021;118:e2021785118. doi: 10.1073/pnas.2021785118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2021785118</ArticleId><ArticleId IdType="pmc">PMC7812859</ArticleId><ArticleId IdType="pubmed">33361333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Xia T, Shin W-J, Yu K-M, Jung W, et al. Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8. mBio. 2022;13:e0040222. doi: 10.1128/mbio.00402-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00402-22</ArticleId><ArticleId IdType="pmc">PMC9040823</ArticleId><ArticleId IdType="pubmed">35343786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Fu B, Yin S, Li Z, Liu H, et al. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience. 2021;24:102293. doi: 10.1016/j.isci.2021.102293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102293</ArticleId><ArticleId IdType="pmc">PMC7942160</ArticleId><ArticleId IdType="pubmed">33723527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Chen Y, Li Y, Huang F, Luo B, et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-&#x399;. Proc Natl Acad Sci USA. 2021;118:23. doi: 10.1073/pnas.2024202118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhuang M-W, Deng J, Zheng Y, Zhang J, et al. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J Med Virol. 2021;93:5376&#x2013;5389. doi: 10.1002/jmv.27050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Shi Y, Pan X, Wu S, Hou R, et al. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. 2021;34:108761. doi: 10.1016/j.celrep.2021.108761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108761</ArticleId><ArticleId IdType="pmc">PMC7857071</ArticleId><ArticleId IdType="pubmed">33567255</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, Bouhaddou M, Reuschl A-K, Zuliani-Alvarez L, Polacco B, et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. 2022;604:487&#x2013;495. doi: 10.1038/s41586-022-04653-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04653-w</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayinde KS, Pinheiro GMS, Ramos CHI. Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90. Biochimie. 2022;200:99&#x2013;106. doi: 10.1016/j.biochi.2022.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2022.05.016</ArticleId><ArticleId IdType="pmc">PMC9132681</ArticleId><ArticleId IdType="pubmed">35643212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Zhu K, Qin B, Olieric V, Wang M, et al. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions. Nat Commun. 2021;12 doi: 10.1038/s41467-021-23118-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23118-8</ArticleId><ArticleId IdType="pmc">PMC8121815</ArticleId><ArticleId IdType="pubmed">33990585</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang H, Meng Q, Xie J, Li Y, et al. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol Immunol. 2020;17:998&#x2013;1000. doi: 10.1038/s41423-020-0514-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0514-8</ArticleId><ArticleId IdType="pmc">PMC7387808</ArticleId><ArticleId IdType="pubmed">32728199</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez Andres A, Feng Y, Campos AR, Yin J, Yang C-C, et al. SARS-CoV-2 ORF9c is a membrane-associated protein that suppresses antiviral responses in cells. bioRxiv. 2020:2020.08.18.256776. doi: 10.1101/2020.08.18.256776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.18.256776</ArticleId><ArticleId IdType="pmc">PMC7444281</ArticleId><ArticleId IdType="pubmed">32839770</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zheng Y, Deng J, Nan M-L, Xiao Y, et al. SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Virol. 2022;94:5174&#x2013;5188. doi: 10.1002/jmv.27965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27965</ArticleId><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>